IDEAS home Printed from https://ideas.repec.org/e/c/pcr110.html
   My authors  Follow this author

Luca A. Crivelli

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Luca Crivelli & Paola Salari, 2012. "Fiscal federalism and income redistribution through healthcare financing: An empirical analysis for the Swiss cantons," CEPRA working paper 1204, USI Università della Svizzera italiana.

    Cited by:

    1. Rosella Levaggi & Francesco Menoncin, 2014. "Health care expenditure decisions in the presence of devolution and equalisation grants," International Journal of Health Economics and Management, Springer, vol. 14(4), pages 355-368, December.
    2. Rosella Levaggi & Francesco Menoncin, 2017. "Would less regional income distribution justify the present call for devolution?," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 24(5), pages 780-799, September.

  2. Luca Crivelli & Anna Bracci & Gregorio Avil s, 2012. "Il modello d impresa sociale made in Switzerland . Risultati di un indagine esplorativa condotta su piano nazionale," Euricse Working Papers 1238, Euricse (European Research Institute on Cooperative and Social Enterprises).

    Cited by:

    1. Adam Stefan & Amstutz Jeremias & Enrico Cavedon & Wüthrich Bernadette & Avilés Gregorio & Ferrari Domenico & Crivelli Luca & Gafner Anja & Greppi Spartaco & Schmitz Daniela & Zoebeli Daniel, 2016. "Work Integration Social Enterprises in Switzerland," Nonprofit Policy Forum, De Gruyter, vol. 7(4), pages 509-539, December.
    2. Massimo Cermelli & Umberto Di Maggio & Giuseppe Notarstefano & Giuseppe Terzo, 2019. "Social capital and social entrepreneurship. Cross-country evidence for development and cohesion," RIEDS - Rivista Italiana di Economia, Demografia e Statistica - The Italian Journal of Economic, Demographic and Statistical Studies, SIEDS Societa' Italiana di Economia Demografia e Statistica, vol. 73(2), pages 87-98, April-Jun.

Articles

  1. Erin A. West & Daniela Anker & Rebecca Amati & Aude Richard & Ania Wisniak & Audrey Butty & Emiliano Albanese & Murielle Bochud & Arnaud Chiolero & Luca Crivelli & Stéphane Cullati & Valérie d’Acremon, 2020. "Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(9), pages 1529-1548, December.

    Cited by:

    1. Alessia Raineri & Thomas Radtke & Sonja Rueegg & Sarah R. Haile & Dominik Menges & Tala Ballouz & Agne Ulyte & Jan Fehr & Daniel L. Cornejo & Giuseppe Pantaleo & Céline Pellaton & Craig Fenwick & Milo, 2023. "Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    2. Giovanni Piumatti & Rebecca Amati & Aude Richard & Hélène Baysson & Marianna Purgato & Idris Guessous & Silvia Stringhini & Emiliano Albanese & Specchio-COVID19 Study Group & the Corona Immunitas Tici, 2022. "Associations between Depression and Self-Reported COVID-19 Symptoms among Adults: Results from Two Population-Based Seroprevalence Studies in Switzerland," IJERPH, MDPI, vol. 19(24), pages 1-17, December.
    3. Rebecca Amati & Giovanni Piumatti & Giovanni Franscella & Peter Buttaroni & Anne-Linda Camerini & Laurie Corna & Sara Levati & Marta Fadda & Maddalena Fiordelli & Anna Maria Annoni & Kleona Bezani & A, 2023. "Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study," IJERPH, MDPI, vol. 20(4), pages 1-16, February.

  2. Luca Crivelli & Mario Lucchini, 2017. "Health and happiness: an introduction," International Review of Economics, Springer;Happiness Economics and Interpersonal Relations (HEIRS), vol. 64(2), pages 105-111, June.

    Cited by:

    1. Noelia Somarriba Arechavala & Pilar Zarzosa Espina & Ana Teresa López Pastor, 2022. "The Importance of the Neighbourhood Environment and Social Capital for Happiness in a Vulnerable District: The Case of the Pajarillos District in Spain," Journal of Happiness Studies, Springer, vol. 23(5), pages 1941-1965, June.

  3. Nino Künzli & Luca Crivelli & Dominique Sprumont & Sandra Nocera, 2015. "Does the Swiss School of Public Health exist?," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(8), pages 873-875, December.

    Cited by:

    1. Anke Berger & Nino Künzli, 2018. "Welcome to the third training pillar of IJPH: Young Researcher Editorials," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 63(9), pages 1009-1010, December.
    2. Jacqueline Müller-Nordhorn & Vesna Bjegovic-Mikanovic & Robert Otok & Katarzyna Czabanowska & Anders Foldspang, 2016. "Fifty years of serving public health: the Association of Schools of Public Health in the European Region moving forward to the next half-century," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 61(6), pages 631-632, July.
    3. Thomy Tonia & Herman Van Oyen & Anke Berger & Christian Schindler & Nino Künzli, 2016. "If I tweet will you cite? The effect of social media exposure of articles on downloads and citations," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 61(4), pages 513-520, May.

  4. Mario Lucchini & Sara Della Bella & Luca Crivelli, 2015. "Social capital and life satisfaction in Switzerland," International Journal of Happiness and Development, Inderscience Enterprises Ltd, vol. 2(3), pages 250-268.

    Cited by:

    1. John Helliwell & Haifang Huang & Shun Wang, 2016. "New Evidence on Trust and Well-Being," Working Papers id:11131, eSocialSciences.
    2. Calcagnini, Giorgio & Perugini, Francesco, 2019. "Social capital and well-being in the Italian provinces," Socio-Economic Planning Sciences, Elsevier, vol. 68(C).

  5. De Pietro, Carlo & Crivelli, Luca, 2015. "Swiss popular initiative for a single health insurer… once again!," Health Policy, Elsevier, vol. 119(7), pages 851-855.

    Cited by:

    1. Maarse, Hans & Jeurissen, Patrick, 2019. "Low institutional trust in health insurers in Dutch health care," Health Policy, Elsevier, vol. 123(3), pages 288-292.
    2. Nicolet, Anna & Perraudin, Clémence & Krucien, Nicolas & Wagner, Joël & Peytremann-Bridevaux, Isabelle & Marti, Joachim, 2023. "Preferences of older adults for healthcare models designed to improve care coordination: Evidence from Western Switzerland," Health Policy, Elsevier, vol. 132(C).

  6. Thomson, Sarah & Busse, Reinhard & Crivelli, Luca & van de Ven, Wynand & Van de Voorde, Carine, 2013. "Statutory health insurance competition in Europe: A four-country comparison," Health Policy, Elsevier, vol. 109(3), pages 209-225.

    Cited by:

    1. Christian Bührer & Stefan Fetzer & Christian Hagist, 2018. "Adverse Selection in the German Health Insurance System – The Case of Civil Servants," WHU Working Paper Series - Economics Group 18-06, WHU - Otto Beisheim School of Management.
    2. Noort, Bart A.C. & Ahaus, Kees & van der Vaart, Taco & Chambers, Naomi & Sheaff, Rod, 2020. "How healthcare systems shape a purchaser’s strategies and actions when managing chronic care," Health Policy, Elsevier, vol. 124(6), pages 628-638.
    3. Mark Stabile & Sarah Thomson, 2014. "The Changing Role of Government in Financing Health Care: An International Perspective," Journal of Economic Literature, American Economic Association, vol. 52(2), pages 480-518, June.
    4. Connolly, Sheelah & Wren, Maev-Ann, 2016. "The 2011 proposal for Universal Health Insurance in Ireland: Potential implications for healthcare expenditure," Health Policy, Elsevier, vol. 120(7), pages 790-796.
    5. Keegan, Conor & Teljeur, Conor & Turner, Brian & Thomas, Steve, 2018. "Switching benefits and costs in the Irish health insurance market: an analysis of consumer surveys," Papers RB201820, Economic and Social Research Institute (ESRI).
    6. van der Hulst, Frank J.P. & Holst, Laurens & Brabers, Anne E.M. & de Jong, Judith D., 2022. "To what degree are health insurance enrollees in the Netherlands aware of the restrictive conditions attached to their policies?," Health Policy, Elsevier, vol. 126(7), pages 693-703.
    7. Bes, Romy E. & Curfs, Emile C. & Groenewegen, Peter P. & de Jong, Judith D., 2017. "Selective contracting and channelling patients to preferred providers: A scoping review," Health Policy, Elsevier, vol. 121(5), pages 504-514.
    8. Roman-Urrestarazu, Andres & Yang, Justin C. & Ettelt, Stefanie & Thalmann, Inna & Seguel Ravest, Valeska & Brayne, Carol, 2018. "Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict," LSE Research Online Documents on Economics 90055, London School of Economics and Political Science, LSE Library.
    9. Klink, Ab & Schakel, H. Christiaan & Visser, Sander & Jeurissen, Patrick, 2017. "The arduous quest for translating health care productivity gains into cost savings. Lessons from their evolution at economic scoring agencies in the Netherlands and the US," Health Policy, Elsevier, vol. 121(1), pages 1-8.
    10. Dalit Daily-Amir & Hansjörg Albrecher & Martin Bladt & Joël Wagner, 2019. "On Market Share Drivers in the Swiss Mandatory Health Insurance Sector," Risks, MDPI, vol. 7(4), pages 1-25, November.
    11. Duijmelinck, Daniëlle M.I.D. & Mosca, Ilaria & van de Ven, Wynand P.M.M., 2015. "Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands," Health Policy, Elsevier, vol. 119(5), pages 664-671.
    12. Bührer, Christian & Fetzer, Stefan & Hagist, Christian, 2020. "Adverse selection in the German Health Insurance System – the case of civil servants," Health Policy, Elsevier, vol. 124(8), pages 888-894.
    13. Hermanns, Benedicta & Kairies-Schwarz, Nadja & Kokot, Johanna & Vomhof, Markus, 2023. "Heterogeneity in health insurance choice: An experimental investigation of consumer choice and feature preferences," hche Research Papers 29, University of Hamburg, Hamburg Center for Health Economics (hche).
    14. Giammanco, Maria Daniela & Gitto, Lara, 2019. "Health expenditure and FDI in Europe," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 255-267.
    15. Nicolet, Anna & Perraudin, Clémence & Krucien, Nicolas & Wagner, Joël & Peytremann-Bridevaux, Isabelle & Marti, Joachim, 2023. "Preferences of older adults for healthcare models designed to improve care coordination: Evidence from Western Switzerland," Health Policy, Elsevier, vol. 132(C).
    16. Edith Maier & Ulrich Reimer & Nilmini Wickramasinghe, 2021. "Digital healthcare services," Electronic Markets, Springer;IIM University of St. Gallen, vol. 31(4), pages 743-746, December.
    17. World Bank, 2017. "Georgia Public Expenditure Review," World Bank Publications - Reports 27138, The World Bank Group.
    18. Kairies-Schwarz, Nadja & Kokot, Johanna & Vomhof, Markus & Weßling, Jens, 2017. "Health insurance choice and risk preferences under cumulative prospect theory – an experiment," Journal of Economic Behavior & Organization, Elsevier, vol. 137(C), pages 374-397.
    19. Becker, Christian & Holle, Rolf & Stollenwerk, Björn, 2015. "The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention," Health Policy, Elsevier, vol. 119(6), pages 778-786.
    20. Viktor von Wyl & Konstantin Beck, 2016. "Do insurers respond to risk adjustment? A long-term, nationwide analysis from Switzerland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(2), pages 171-183, March.
    21. De Pietro, Carlo & Crivelli, Luca, 2015. "Swiss popular initiative for a single health insurer… once again!," Health Policy, Elsevier, vol. 119(7), pages 851-855.
    22. Tsiachristas, Apostolos & Dikkers, Carolien & Boland, Melinde R.S. & Rutten-van Mölken, Maureen P.M.H., 2013. "Exploring payment schemes used to promote integrated chronic care in Europe," Health Policy, Elsevier, vol. 113(3), pages 296-304.
    23. Bart A C Noort & Taco van der Vaart & Kees Ahaus, 2021. "Orchestration versus bookkeeping: How stakeholder pressures drive a healthcare purchaser’s institutional logics," PLOS ONE, Public Library of Science, vol. 16(10), pages 1-24, October.
    24. Andree Ehlert & Thomas Wein & Peter Zweifel, 2017. "Overcoming resistance against managed care – insights from a bargaining model," Health Economics Review, Springer, vol. 7(1), pages 1-15, December.
    25. Connolly, Sheelah & Wren, Maev-Ann, 2023. "Towards universal healthcare in Ireland – what can we learn from the literature?," Research Series, Economic and Social Research Institute (ESRI), number SUSTAT121, June.
    26. Van der Aa, Maartje J. & Paulus, Aggie T.G. & Klosse, Saskia & Evers, Silvia M.A.A. & Maarse, Johannes A. M., 2019. "The impact of reforms of national health insurance on solidarity in the Netherlands: comparing health care insurance and long-term care insurance," LSE Research Online Documents on Economics 106225, London School of Economics and Political Science, LSE Library.
    27. Kairies-Schwarz, Nadja & Kokot, Johanna & Vomhof, Markus & Wessling, Jens, 2014. "How Do Consumers Choose Health Insurance? – An Experiment on Heterogeneity in Attribute Tastes and Risk Preferences," Ruhr Economic Papers 537, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.

  7. Okma, Kieke G.H. & Crivelli, Luca, 2013. "Swiss and Dutch “consumer-driven health care”: Ideal model or reality?," Health Policy, Elsevier, vol. 109(2), pages 105-112.

    Cited by:

    1. Andree Ehlert & Thomas Wein & Peter Zweifel, 2017. "Overcoming resistance against managed care – insights from a bargaining model," Health Economics Review, Springer, vol. 7(1), pages 1-15, December.

  8. Smith, Peter C. & Anell, Anders & Busse, Reinhard & Crivelli, Luca & Healy, Judith & Lindahl, Anne Karin & Westert, Gert & Kene, Tobechukwu, 2012. "Leadership and governance in seven developed health systems," Health Policy, Elsevier, vol. 106(1), pages 37-49.

    Cited by:

    1. Okma, Kieke G.H. & Crivelli, Luca, 2013. "Swiss and Dutch “consumer-driven health care”: Ideal model or reality?," Health Policy, Elsevier, vol. 109(2), pages 105-112.
    2. Klink, Ab & Schakel, H. Christiaan & Visser, Sander & Jeurissen, Patrick, 2017. "The arduous quest for translating health care productivity gains into cost savings. Lessons from their evolution at economic scoring agencies in the Netherlands and the US," Health Policy, Elsevier, vol. 121(1), pages 1-8.
    3. Tello, Juan E. & Barbazza, Erica & Waddell, Kerry, 2020. "Review of 128 quality of care mechanisms: A framework and mapping for health system stewards," Health Policy, Elsevier, vol. 124(1), pages 12-24.
    4. Changwoo Shon & Myoungsoon You, 2020. "Evaluation of Health Policy Governance in the Introduction of the New DRG-Based Hospital Payment System from Interviews with Policy Elites in South Korea," IJERPH, MDPI, vol. 17(11), pages 1-18, May.
    5. Celia Dana BESCIU, 2013. "Personnel Satisfaction Study regarding the Emergency Medical Services’ Quality of Bucharest Hospitals," REVISTA ADMINISTRATIE SI MANAGEMENT PUBLIC, Faculty of Administration and Public Management, Academy of Economic Studies, Bucharest, Romania, vol. 2013(21), pages 71-83, December.
    6. Glenngård, Anna Häger, 2013. "Productivity and patient satisfaction in primary care—Conflicting or compatible goals?," Health Policy, Elsevier, vol. 111(2), pages 157-165.
    7. Marmor, Theodore & Wendt, Claus, 2012. "Conceptual frameworks for comparing healthcare politics and policy," Health Policy, Elsevier, vol. 107(1), pages 11-20.

  9. Haas, Marion & Ashton, Toni & Blum, Kerstin & Christiansen, Terkel & Conis, Elena & Crivelli, Luca & Lim, Meng Kin & Lisac, Melanie & MacAdam, Margaret & Schlette, Sophia, 2009. "Drugs, sex, money and power: An HPV vaccine case study," Health Policy, Elsevier, vol. 92(2-3), pages 288-295, October.

    Cited by:

    1. Mario García Molina & Liliana Alejandra Chicaíza-Becerra, 2015. "Riesgo, incertidumbre y política pública en vacunas," Revista Cuadernos de Economia, Universidad Nacional de Colombia, FCE, CID, March.
    2. Mezza, Maurizia & Blume, Stuart, 2021. "Turning suffering into side effects: Responses to HPV vaccination in Colombia," Social Science & Medicine, Elsevier, vol. 282(C).
    3. Blume, Stuart & Tump, Janneke, 2010. "Evidence and policymaking: The introduction of MMR vaccine in the Netherlands," Social Science & Medicine, Elsevier, vol. 71(6), pages 1049-1055, September.
    4. Fischer, Katharina E. & Leidl, Reiner & Rogowski, Wolf H., 2011. "A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention," Health Policy, Elsevier, vol. 101(3), pages 290-299, August.
    5. van der Putten, Ingeborg M. & Paulus, Aggie T.G. & Hiligsmann, Mickael & Hutubessy, Raymond C.W. & Evers, Silvia M.A.A., 2019. "Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands," Health Policy, Elsevier, vol. 123(3), pages 260-266.

  10. Luca Crivelli & Massimo Filippini & Ilaria Mosca, 2006. "Federalism and regional health care expenditures: an empirical analysis for the Swiss cantons," Health Economics, John Wiley & Sons, Ltd., vol. 15(5), pages 535-541, May.

    Cited by:

    1. L. Di Matteo & Tom Barbiero, 2019. "Spend Less, Get More? Explaining Health Spending and Outcome Differences Between Canada and Italy," Working Papers 077, Ryerson University, Department of Economics.
    2. Andree Ehlert & Dirk Oberschachtsiek & Stefan Prawda, 2013. "Cost Containment and Managed Care: Evidence from German Macro Data," Working Paper Series in Economics 284, University of Lüneburg, Institute of Economics.
    3. Badi H. Baltagi & Raffaele Lagravinese & Francesco Moscone & Elisa Tosetti, 2016. "The Health Care Expenditure and Income: A Global Perspective," Center for Policy Research Working Papers 197, Center for Policy Research, Maxwell School, Syracuse University.
    4. Braendle, Thomas & Colombier, Carsten, 2016. "What drives public health care expenditure growth? Evidence from Swiss cantons, 1970–2012," Health Policy, Elsevier, vol. 120(9), pages 1051-1060.
    5. Giardina, Emilio & Cavalieri, Marina & Guccio, Calogero & Mazza, Isidoro, 2009. "Federalism, Party Competition and Budget Outcome: Empirical Findings on Regional Health Expenditure in Italy," MPRA Paper 16437, University Library of Munich, Germany.
    6. Gastón Illanes & Manisha Padi, 2019. "Retirement Policy and Annuity Market Equilibria: Evidence from Chile," NBER Working Papers 26285, National Bureau of Economic Research, Inc.
    7. Schmidheiny, Kurt & Luthi, Eva, 2011. "The Effect of Agglomeration Size on Local Taxes," CEPR Discussion Papers 8344, C.E.P.R. Discussion Papers.
    8. Rita De Siano & Marcella D'Uva, 2013. "Does decentralization affect regional public spending in Italy?," Discussion Papers 1_2013, CRISEI, University of Naples "Parthenope", Italy.
    9. Massimiliano Piacenza & Gilberto Turati, 2010. "Does fiscal discipline towards sub-national governments affect citizens’ well-being? evidence on health," Working Papers 2010/56, Institut d'Economia de Barcelona (IEB).
    10. Martínez André & Rodríguez-Zamora Carolina, 2011. "An Evaluation of the 1997 Fiscal Decentralization Reform in Mexico: The Case of the Health Sector," Working Papers 2011-16, Banco de México.
    11. Jochen Hartwig & Jan-Egbert Sturm, 2017. "Testing the Grossman model of medical spending determinants with macroeconomic panel data," KOF Working papers 17-426, KOF Swiss Economic Institute, ETH Zurich.
    12. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Monica Auteri & Guido Borà, 2017. "La spesa sanitaria delle Regioni in Italia - Saniregio2017," Working Papers CERM 01-2017, Competitività, Regole, Mercati (CERM).
    13. Jochen Hartwig & Jan-Egbert Sturm, 2012. "An outlier-robust extreme bounds analysis of the determinants of health-care expenditure growth," KOF Working papers 12-307, KOF Swiss Economic Institute, ETH Zurich.
    14. Luca Crivelli & Paola Salari, 2012. "Fiscal federalism and income redistribution through healthcare financing: An empirical analysis for the Swiss cantons," CEPRA working paper 1204, USI Università della Svizzera italiana.
    15. Masayoshi Hayashi, 2011. "The Effects of Medical Factors on Transfer Deficits in Public Assistance in Japan: A Quantile Regression Analysis," CIRJE F-Series CIRJE-F-816, CIRJE, Faculty of Economics, University of Tokyo.
    16. Hai Zhong, 2010. "The impact of decentralization of health care administration on equity in health and health care in Canada," International Journal of Health Economics and Management, Springer, vol. 10(3), pages 219-237, September.
    17. Costa-i-Font, Joan & Gemmill, Marin & Rubert, Gloria, 2009. "Re-visiting the health care luxury good hypothesis: aggregation, precision, and publication biases?," LSE Research Online Documents on Economics 25303, London School of Economics and Political Science, LSE Library.
    18. Boris Kaiser & Christian Schmid, 2016. "Does Physician Dispensing Increase Drug Expenditures? Empirical Evidence from Switzerland," Health Economics, John Wiley & Sons, Ltd., vol. 25(1), pages 71-90, January.
    19. Okma, Kieke G.H. & Crivelli, Luca, 2013. "Swiss and Dutch “consumer-driven health care”: Ideal model or reality?," Health Policy, Elsevier, vol. 109(2), pages 105-112.
    20. Błażej Łyszczarz, 2018. "Determinanty wydatków na zdrowie w gospodarstwach domowych w Polsce," Gospodarka Narodowa. The Polish Journal of Economics, Warsaw School of Economics, issue 1, pages 137-157.
    21. Mark Pletscher, 2017. "The effects of organized screening programs on the demand for mammography in Switzerland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(5), pages 649-665, June.
    22. Mosca, Ilaria, 2006. "Is decentralisation the real solution?: A three country study," Health Policy, Elsevier, vol. 77(1), pages 113-120, June.
    23. Stefan Felder & Andreas Werblow, 2009. "The Marginal Cost of Saving a Life in Health Care: Age, Gender and Regional Differences in Switzerland," Swiss Journal of Economics and Statistics (SJES), Swiss Society of Economics and Statistics (SSES), vol. 145(II), pages 137-153, June.
    24. Oliver Reich & Cornelia Weins & Claudia Schusterschitz & Magdalena Thöni, 2012. "Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(2), pages 193-202, April.
    25. Carsten Colombier & Thomas Braendle, 2018. "Healthcare expenditure and fiscal sustainability: evidence from Switzerland," Public Sector Economics, Institute of Public Finance, vol. 42(3), pages 279-301.
    26. Jay Pan & Gordon G. Liu, 2012. "The Determinants Of Chinese Provincial Government Health Expenditures: Evidence From 2002–2006 Data," Health Economics, John Wiley & Sons, Ltd., vol. 21(7), pages 757-777, July.
    27. Joan Costa‐Font & Marin Gemmill & Gloria Rubert, 2011. "Biases in the healthcare luxury good hypothesis?: a meta‐regression analysis," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 174(1), pages 95-107, January.
    28. Lopreite, Milena & Misuraca, Michelangelo & Puliga, Michelangelo, 2023. "An analysis of the thematic evolution of ageing and healthcare expenditure using word embedding: A scoping review of policy implications," Socio-Economic Planning Sciences, Elsevier, vol. 87(PB).
    29. Silvia Fedeli, 2015. "The Impact of GDP on Health Care Expenditure: The Case of Italy (1982–2009)," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 122(2), pages 347-370, June.
    30. Kaufmann, Cornel & Schmid, Christian & Boes, Stefan, 2017. "Health insurance subsidies and deductible choice: Evidence from regional variation in subsidy schemes," Journal of Health Economics, Elsevier, vol. 55(C), pages 262-273.
    31. Vandersteegen, Tom & Marneffe, Wim & Cleemput, Irina & Vereeck, Lode, 2015. "The impact of no-fault compensation on health care expenditures: An empirical study of OECD countries," Health Policy, Elsevier, vol. 119(3), pages 367-374.
    32. Héctor Bellido & Lorena Olmos & Juan Antonio Román-Aso, 2019. "Do political factors influence public health expenditures? Evidence pre- and post-great recession," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 455-474, April.
    33. Braendle, Thomas & Colombier, Carsten, 2017. "Healthcare expenditure projections up to 2045," MPRA Paper 104737, University Library of Munich, Germany.
    34. Schleiniger, Reto, 2014. "Health care cost in Switzerland: Quantity- or price-driven?," Health Policy, Elsevier, vol. 117(1), pages 83-89.
    35. Eggli, Yves & Stadelmann, Pierre & Piaget-Rossel, Romain & Marti, Joachim, 2019. "Heterogeneity in The drivers of health expenditures financed by health insurance in a fragmented health system: The case of Switzerland," Health Policy, Elsevier, vol. 123(12), pages 1275-1281.
    36. Jamiil Jeetoo, 2020. "Spillover effects in public healthcare expenditure in Sub‐Saharan Africa: A spatial panel analysis," African Development Review, African Development Bank, vol. 32(2), pages 257-268, June.
    37. Lamiraud, Karine & Lhuillery, Stephane, 2015. "Endogenous Technology Adoption and Medical Costs," ESSEC Working Papers WP1518, ESSEC Research Center, ESSEC Business School.
    38. Ahmad, Ehtisham & Brosio, Giorgio, 2009. "Decentralization and local service provision: what do we know?," LSE Research Online Documents on Economics 38347, London School of Economics and Political Science, LSE Library.
    39. Tobias Schoch & André Müller, 2020. "Treatment of sample under-representation and skewed heavy-tailed distributions in survey-based microsimulation: An analysis of redistribution effects in compulsory health care insurance in Switzerland," AStA Wirtschafts- und Sozialstatistisches Archiv, Springer;Deutsche Statistische Gesellschaft - German Statistical Society, vol. 14(3), pages 267-304, December.
    40. Di Matteo, Livio & Cantarero-Prieto, David, 2018. "The Determinants of Public Health Expenditures: Comparing Canada and Spain," MPRA Paper 87800, University Library of Munich, Germany.
    41. Del Vecchio, Mario & Fenech, Lorenzo & Prenestini, Anna, 2015. "Private health care expenditure and quality in Beveridge systems: Cross-regional differences in the Italian NHS," Health Policy, Elsevier, vol. 119(3), pages 356-366.
    42. Andree Ehlert & Dirk Oberschachtsiek, 2014. "Does managed care reduce health care expenditure? Evidence from spatial panel data," International Journal of Health Economics and Management, Springer, vol. 14(3), pages 207-227, September.
    43. Bettin, Giulia & Sacchi, Agnese, 2020. "Health spending in Italy: The impact of immigrants," European Journal of Political Economy, Elsevier, vol. 65(C).
    44. Esra N. Kilci, 2021. "A study on financial sustainability of healthcare indicators for Turkey under the health transformation program," International Journal of Health Planning and Management, Wiley Blackwell, vol. 36(4), pages 1287-1307, July.
    45. Kabaya, Kei, 2021. "Empirical analysis of associations between health expenditure and forest environments: A case of Japan," Ecological Economics, Elsevier, vol. 181(C).
    46. Caravaggio, Nicola & Resce, Giuliano, 2023. "Enhancing Healthcare Cost Forecasting: A Machine Learning Model for Resource Allocation in Heterogeneous Regions," Economics & Statistics Discussion Papers esdp23090, University of Molise, Department of Economics.
    47. Boris Kaiser & Christian Schmid, 2013. "Does Physician Dispensing Increase Drug Expenditures?," Diskussionsschriften dp1303, Universitaet Bern, Departement Volkswirtschaft.
    48. Lagravinese, Raffaele & Paradiso, Massimo, 2012. "Corruption and health expenditure in Italy," MPRA Paper 43215, University Library of Munich, Germany.
    49. Moscone, Francesco & Knapp, Martin & Tosetti, Elisa, 2007. "Mental health expenditure in England: A spatial panel approach," Journal of Health Economics, Elsevier, vol. 26(4), pages 842-864, July.
    50. Saqib Amin & Ruhamah Yousaf & Muhammad Awais Anwar & Noman Arshed, 2022. "Assessing the impact of diversity and ageing population on health expenditure of United States," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(2), pages 913-929, March.
    51. Colombier, Carsten, 2016. "Population aging in healthcare - a minor issue? Evidence from Switzerland," FiFo Discussion Papers - Finanzwissenschaftliche Diskussionsbeiträge 16-3, University of Cologne, FiFo Institute for Public Economics.
    52. Di Matteo, Livio, 2014. "Physician numbers as a driver of provincial government health spending in Canadian health policy," Health Policy, Elsevier, vol. 115(1), pages 18-35.
    53. Rosella Levaggi & Francesco Menoncin, 2017. "Would less regional income distribution justify the present call for devolution?," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 24(5), pages 780-799, September.
    54. Muhammad Arshad Khan & Muhammad Iftikhar Ul Husnain, 2019. "Is health care a luxury or necessity good? Evidence from Asian countries," International Journal of Health Economics and Management, Springer, vol. 19(2), pages 213-233, June.
    55. Jochen Hartwig & Jan-Egbert Sturm, 2014. "Robust determinants of health care expenditure growth," Applied Economics, Taylor & Francis Journals, vol. 46(36), pages 4455-4474, December.
    56. David Prieto & Santiago Lago-Peñas, 2012. "Decomposing the determinants of health care expenditure: the case of Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(1), pages 19-27, February.
    57. Mr. Ehtisham Ahmad & Mr. Giorgio Brosio & Mr. Vito Tanzi, 2008. "Local Service Provision in Selected OECD Countries: Do Decentralized Operations Work Better?," IMF Working Papers 2008/067, International Monetary Fund.

  11. Massimo Filippini & Diego Lunati & Luca Crivelli, 2001. "Dimensione ottima degli ospedali in uno Stato federale," ECONOMIA PUBBLICA, FrancoAngeli Editore, vol. 2001(5).

    Cited by:

    1. Giovanni Iuzzolino, 2008. "Demand and supply of hospital services. International trends," Questioni di Economia e Finanza (Occasional Papers) 27, Bank of Italy, Economic Research and International Relations Area.
    2. Antonello Maruotti, 2009. "Fairness of the national health service in Italy: a bivariate correlated random effects model," Journal of Applied Statistics, Taylor & Francis Journals, vol. 36(7), pages 709-722.
    3. Mehdi Farsi & Massimo Filippini, 2008. "Effects of ownership, subsidization and teaching activities on hospital costs in Switzerland," Health Economics, John Wiley & Sons, Ltd., vol. 17(3), pages 335-350, March.

  12. Zweifel, Peter & Crivelli, Luca, 1996. "Price Regulation of Drugs: Lessons from Germany," Journal of Regulatory Economics, Springer, vol. 10(3), pages 257-273, November.

    Cited by:

    1. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    2. Carol Adams & Nongnooch Kuasirikun, 2000. "A comparative analysis of corporate reporting on ethical issues by UK and German chemical and pharmaceutical companies," European Accounting Review, Taylor & Francis Journals, vol. 9(1), pages 53-79.
    3. Guillem López & Jaume Puig, 1999. "Review of the literature on reference pricing," Economics Working Papers 362, Department of Economics and Business, Universitat Pompeu Fabra.
    4. Danzon Patricia M. & Ketcham Jonathan D., 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-56, January.
    5. Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås, 2007. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," CESifo Working Paper Series 2059, CESifo.
    6. Moshe Yanovskiy & Yehoshua Socol, 2022. "Are Lockdowns Effective in Managing Pandemics?," IJERPH, MDPI, vol. 19(15), pages 1-12, July.
    7. Jorge Mestre-Ferrandiz, 2000. "Reference Prices: The Spanish Way," UFAE and IAE Working Papers 481.01, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
    8. Saglam, Ismail, 2022. "Incentives of a Monopolist for Innovation under Regulatory Threat," MPRA Paper 113155, University Library of Munich, Germany.
    9. Magnezi, Racheli & Weiss, Yossi & Cohen, Yossi & Shmueli, Amir, 2007. "Development of a capitation scale for IDF career soldiers in Israel," Health Policy, Elsevier, vol. 80(3), pages 459-464, March.
    10. Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006. "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series 1825, CESifo.
    11. Jaume Puig, 2005. "The impact of generic reference pricing interventions in the statin market," Working Papers, Research Center on Health and Economics 906, Department of Economics and Business, Universitat Pompeu Fabra.
    12. Peter Kotzian, 2002. "Stuck in the Middle: Welfare Effects of the European Pharmaceutical Markets' Incomplete Integration and a Possible Remedy," MZES Working Papers 59, MZES.
    13. Anna Merino, 2000. "The impact of the reference price system on the pharmaceutical market: A theoretical approach," Economics Working Papers 524, Department of Economics and Business, Universitat Pompeu Fabra, revised Jun 2003.
    14. Puig-Junoy, Jaume, 2007. "The impact of generic reference pricing interventions in the statin market," Health Policy, Elsevier, vol. 84(1), pages 14-29, November.
    15. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico," Working Papers CERM 04-2007, Competitività, Regole, Mercati (CERM).
    16. Jaume Puig, 2005. "The impact of generic reference pricing interventions in the statin market," Economics Working Papers 906, Department of Economics and Business, Universitat Pompeu Fabra.
    17. Caroline Elliott & Melinda Acutt, 2007. "Antitrust Policy: The Impact of Revenue Penalties on Price," Journal of Industry, Competition and Trade, Springer, vol. 7(1), pages 1-8, March.
    18. Paul V. Grootendorst & John K. Marshall & Anne M. Holbrook & Lisa R. Dolovich & Bernie J. O'Brien & Adrian R. Levy, 2004. "The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs," Social and Economic Dimensions of an Aging Population Research Papers 115, McMaster University.
    19. Anne Maria Busch, 2015. "Drug Prices and Pressure Group Activities in the German Health Care Market: An Application of the Becker Model," Working Paper Series in Economics 338, University of Lüneburg, Institute of Economics.
    20. Anna Merino, 2000. "The impact of the reference price system on the pharmaceutical market: A theoretical approach," Working Papers, Research Center on Health and Economics 524, Department of Economics and Business, Universitat Pompeu Fabra, revised Jun 2003.
    21. Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Working Papers, Research Center on Health and Economics 662, Department of Economics and Business, Universitat Pompeu Fabra.
    22. Puig-Junoy, Jaume & Moreno-Torres, Iván, 2010. "Do generic firms and the Spanish public purchaser respond to consumer price differences of generics under reference pricing?," Health Policy, Elsevier, vol. 98(2-3), pages 186-194, December.
    23. Nina Pavcnik, 2000. "Do Pharmaceutical Prices Respond to Insurance?," NBER Working Papers 7865, National Bureau of Economic Research, Inc.
    24. Nell, Martin & Richter, Andreas & Schiller, Jörg, 2005. "When prices hardly matter: Incomplete insurance contracts and markets for repair goods," Working Papers on Risk and Insurance 14, University of Hamburg, Institute for Risk and Insurance.
    25. Boris Augurzky & Silja Göhlmann & Stefan Greß & Jürgen Wasem, 2009. "Effects of the German reference drug program on ex‐factory prices of prescription drugs: a panel data approach," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 421-436, April.
    26. Ghislandi, Simone, 2011. "Competition and the Reference Pricing Scheme for pharmaceuticals," Journal of Health Economics, Elsevier, vol. 30(6), pages 1137-1149.
    27. John Yfantopoulos, 2008. "Pharmaceutical pricing and reimbursement reforms in Greece," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(1), pages 87-97, February.
    28. Joan Ramon Borrell Arque, 2001. "Drug price differentials caused by de-listing and price cap policies," Working Papers in Economics 70, Universitat de Barcelona. Espai de Recerca en Economia.
    29. Carine Franc & Laurent Granier & Sébastien Trinquard, 2013. "Tarif forfaitaire de responsabilité : quels impacts sur le pharmacien ?," Working Papers 1309, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
    30. Richter, Andreas & Weber, Frederik, 2009. "Mortality-Indexed Annuities," Discussion Papers in Business Administration 10994, University of Munich, Munich School of Management.
    31. C F Elliott & M Z Acutt, 2001. "Threat-based regulation and endogenously determined punishments," Working Papers 539877, Lancaster University Management School, Economics Department.
    32. Acutt, Melinda & Elliott, Caroline & Robinson, Terry, 2001. "Credible regulatory threats," Energy Policy, Elsevier, vol. 29(11), pages 911-916, September.
    33. Königbauer, Ingrid, 2006. "Dealing with Rising Health Care Costs: The Case of Pharmaceuticals," Munich Dissertations in Economics 5640, University of Munich, Department of Economics.
    34. Anne Maria Busch, 2015. "Drug Prices, Rents, and Votes in the German Health Care Market: An Application of the Peltzman Model," Working Paper Series in Economics 339, University of Lüneburg, Institute of Economics.
    35. Brian H. MacGillivray, 2019. "Null Hypothesis Testing ≠ Scientific Inference: A Critique of the Shaky Premise at the Heart of the Science and Values Debate, and a Defense of Value‐Neutral Risk Assessment," Risk Analysis, John Wiley & Sons, vol. 39(7), pages 1520-1532, July.
    36. Melinda Acutt & Caroline Elliott, 2001. "Threat-Based Competition Policy," European Journal of Law and Economics, Springer, vol. 11(3), pages 309-317, May.
    37. Matteo Galizzi & Simone Ghislandi & Marisa Miraldo, 2011. "Effects of Reference Pricing in Pharmaceutical Markets," PharmacoEconomics, Springer, vol. 29(1), pages 17-33, January.

Chapters

  1. Luca Crivelli & Sara Della Bella & Mario Lucchini, 2016. "Happiness and health," Chapters, in: Luigino Bruni & Pier Luigi Porta (ed.), Handbook of Research Methods and Applications in Happiness and Quality of Life, chapter 17, pages 372-399, Edward Elgar Publishing.

    Cited by:

    1. John Helliwell & Haifang Huang & Shun Wang, 2016. "New Evidence on Trust and Well-Being," Working Papers id:11131, eSocialSciences.
    2. Luca Crivelli & Mario Lucchini, 2017. "Health and happiness: an introduction," International Review of Economics, Springer;Happiness Economics and Interpersonal Relations (HEIRS), vol. 64(2), pages 105-111, June.
    3. Piper, Alan T., 2018. "Adult life satisfaction: largely (though not wholly) contemporaneous? A System General Method of Moments dynamic panel analysis," MPRA Paper 85601, University Library of Munich, Germany.
    4. Alan Piper, 2018. "Adult life satisfaction largely (though not wholly) contemporaneous," Discussion Papers 028, Europa-Universität Flensburg, International Institute of Management.

  2. Mario Lucchini & Sara Della Bella & Luca Crivelli, 2016. "Genetic and environmental contributions to life satisfaction," Chapters, in: Luigino Bruni & Pier Luigi Porta (ed.), Handbook of Research Methods and Applications in Happiness and Quality of Life, chapter 9, pages 176-195, Edward Elgar Publishing.

    Cited by:

    1. Luca Crivelli & Mario Lucchini, 2017. "Health and happiness: an introduction," International Review of Economics, Springer;Happiness Economics and Interpersonal Relations (HEIRS), vol. 64(2), pages 105-111, June.

  3. Luca Crivelli & Paola Salari, 2014. "The Impact of Federalism on the Healthcare System in Terms of Efficiency, Equity, and Cost Containment: The Case of Switzerland," Developments in Health Economics and Public Policy, in: Rosella Levaggi & Marcello Montefiori (ed.), Health Care Provision and Patient Mobility, edition 127, pages 155-178, Springer.

    Cited by:

    1. Penno, Erin & Sullivan, Trudy & Barson, Dave & Gauld, Robin, 2021. "Private choices, public costs: Evaluating cost-shifting between private and public health sectors in New Zealand," Health Policy, Elsevier, vol. 125(3), pages 406-414.
    2. Spiess, Adrian Andrea Flavio & Skempes, Dimitrios & Bickenbach, Jerome & Stucki, Gerold, 2022. "Exploration of current challenges in rehabilitation from the perspective of healthcare professionals: Switzerland as a case in point," Health Policy, Elsevier, vol. 126(3), pages 173-182.

  4. Luca Crivelli & Gianfranco Domenighetti & Massimo Filippini, 2007. "Federalism Versus Social Citizenship: Investigating the Preference for Equity in Health Care," Chapters, in: Luigino Bruni & Pier Luigi Porta (ed.), Handbook on the Economics of Happiness, chapter 22, Edward Elgar Publishing.

    Cited by:

    1. Okma, Kieke G.H. & Crivelli, Luca, 2013. "Swiss and Dutch “consumer-driven health care”: Ideal model or reality?," Health Policy, Elsevier, vol. 109(2), pages 105-112.
    2. De Pietro, Carlo & Crivelli, Luca, 2015. "Swiss popular initiative for a single health insurer… once again!," Health Policy, Elsevier, vol. 119(7), pages 851-855.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.